ArticleTranslational oncology2026

CXCL9 drives lung adenocarcinoma progression and immunotherapy response via activation of the CXCR3/JAK1/STAT3 signaling pathway.

Qing Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.